Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Pralidoxime Chloride/Methyl Sulfate Manufacturing

Active
International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract involves the manufacture and supply of Pralidoxime chloride or methyl sulfate in solution or powder form for injection to support prime contractors on Department of National Defence projects. The required product must have a dosage strength of at least 200 mg per container and a minimum shelf-life of 36 months. The selected provider is responsible for conducting stability testing, providing quality assurance certification, and delivering complete treatment courses along with stability reports and product monographs. To be eligible, the manufacturer must hold a Health Canada Notice of Compliance under Division 8 or Division 11 authorization. This global procurement opportunity is managed by the Government of Canada and allows for performance across various international regions. Interested parties must submit their responses by November 10, 2026.

General Info

Supply Pralidoxime chloride for Canada DND projects; Health Canada authorization required by November 2026.

Place of Performance

Canada, South America, United States of America, Mexico, Africa, Asia, Caribbean, Central America, Europe, Oceania, Aboriginal , CAN

Set-Aside

NONE

Documents

This scope was carved out of W6369-26-A033/B.

The full solicitation package (6 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Pralidoxime

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Department of National Defence
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supplies Pralidoxime solution or powder for injection for prime contractors on Department of National Defence projects. Manufactures Pralidoxime chloride or methyl sulfate with dosage strength >= 200 mg per container and 36-month shelf-life. Performs stability testing and provides QA certification. Requires Health Canada Notice of Compliance (Division 8) or Division 11 authorization. Delivers treatment courses, stability reports, and product monographs.

Similar Contracts

Same NAICS industry code

More opportunities from Government of Canada → Department of National Defence

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS